Healthpeak Properties vs Medical Properties Trust
DOC and MPT side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DOC and MPT compare
Healthpeak Properties is the larger company, worth 9.8 times as much as Medical Properties Trust ($13.1B against $1.3B).
Medical Properties Trust grew revenue faster over the last twelve months (10.6% versus 5.5% for Healthpeak Properties).
Healthpeak Properties keeps more of each dollar of sales as profit, with a net margin of 8.2% compared with −3.0% at Medical Properties Trust.
Both pay dividends: Healthpeak Properties yields 6.4% and Medical Properties Trust 16.0%.
Medical Properties Trust scores higher on the StockData Score (9 against 8 for Healthpeak Properties), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DOC | MPT |
|---|---|---|
| Size and price | ||
| Market cap | $13.1B | $1.3B |
| Share price | $19.03 | $2.25 |
| Change, 1 year | 8.2% | −53.7% |
| Change, 5 years | −44.4% | −89.3% |
| Beta (5Y) | 0.73 | 1.18 |
| Employees | 411 | 121 |
| StockData Score | ||
| Total score | 8 | 9 (better) |
| Valuation score | 1 | 4 (better) |
| Growth score | 4 (better) | 1 |
| Performance score | 0 | 1 (better) |
| Health score | 0 | 0 |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | 54.4× | – |
| P/S | 4.4× | 1.3× (better) |
| P/B | 1.7× | 0.3× (better) |
| EV/EBITDA | 7.0× | 1.2× (better) |
| Fair value | $17.22 | $8.41 |
| Margin of safety | −10.5% | 73.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.5% | 10.6% (better) |
| Revenue growth, 5Y average | 11.4% (better) | −4.9% |
| Net income growth (TTM) | 47.5% | – |
| EPS growth (TTM) | 45.8% | – |
| EPS growth, 5Y average | −33.5% | – |
| Profitability | ||
| Net margin | 8.2% (better) | −3.0% |
| Return on equity | 3.1% (better) | −0.65% |
| Financial health | ||
| Altman Z-score | 0.78 (better) | −0.25 |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 6.4% | 16.0% (better) |
| Payout ratio | 348% | – |
| Years of dividend growth | 1 (better) | 0 |
| Dividend growth, 5Y average | −3.8% (better) | −21.4% |
| Buyback yield | 0.77% | – |
| Shareholder yield | 7.2% | 16.0% (better) |
| Ownership | ||
| Held by institutions | 95.9% | 61.1% |
| Held by insiders | 0.36% | 2.3% |
| Insider net buying, 12 months | −$214K (better) | −$297K |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 3.4% | 25.0% |
Go deeper
- DOC stock overview
- DOC income statement
- DOC valuation and score
- MPT stock overview
- MPT income statement
- MPT valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.